Harris-White Marni E, Ferbas Kathie G, Johnson Ming F, Eslami Pirooz, Poteshkina Aleksandra, Venkova Kalina, Christov Alexandar, Hensley Kenneth
Veterans Administration-Greater Los Angeles Healthcare System, Los Angeles, USA; David Geffen School of Medicine at the University of California, Los Angeles, USA.
Veterans Administration-Greater Los Angeles Healthcare System, Los Angeles, USA; Pepperdine University, Seaver College, Natural Sciences Division, Malibu, CA, USA.
Neurobiol Dis. 2015 Dec;84:60-8. doi: 10.1016/j.nbd.2015.03.007. Epub 2015 Mar 14.
Autophagy is a fundamental cellular recycling process vulnerable to compromise in neurodegeneration. We now report that a cell-penetrating neurotrophic and neuroprotective derivative of the central nervous system (CNS) metabolite, lanthionine ketimine (LK), stimulates autophagy in RG2 glioma and SH-SY5Y neuroblastoma cells at concentrations within or below pharmacological levels reported in previous mouse studies. Autophagy stimulation was evidenced by increased lipidation of microtubule-associated protein 1 light chain 3 (LC3) both in the absence and presence of bafilomycin-A1 which discriminates between effects on autophagic flux versus blockage of autophagy clearance. LKE treatment caused changes in protein level or phosphorylation state of multiple autophagy pathway proteins including mTOR; p70S6 kinase; unc-51-like-kinase-1 (ULK1); beclin-1 and LC3 in a manner essentially identical to effects observed after rapamycin treatment. The LKE site of action was near mTOR because neither LKE nor the mTOR inhibitor rapamycin affected tuberous sclerosis complex (TSC) phosphorylation status upstream from mTOR. Confocal immunofluorescence imaging revealed that LKE specifically decreased mTOR (but not TSC2) colocalization with LAMP2(+) lysosomes in RG2 cells, a necessary event for mTORC1-mediated autophagy suppression, whereas rapamycin had no effect. Suppression of the LK-binding adaptor protein CRMP2 (collapsin response mediator protein-2) by means of shRNA resulted in diminished autophagy flux, suggesting that the LKE action on mTOR localization may occur through a novel mechanism involving CRMP2-mediated intracellular trafficking. These findings clarify the mechanism-of-action for LKE in preclinical models of CNS disease, while suggesting possible roles for natural lanthionine metabolites in regulating CNS autophagy.
自噬是一种基本的细胞回收过程,在神经退行性变中容易受到损害。我们现在报告,中枢神经系统(CNS)代谢物兰硫氨酸酮亚胺(LK)的一种细胞穿透性神经营养和神经保护衍生物,在先前小鼠研究报道的药理水平或以下浓度下,可刺激RG2胶质瘤细胞和SH-SY5Y神经母细胞瘤细胞中的自噬。在有无巴佛洛霉素A1的情况下,微管相关蛋白1轻链3(LC3)脂化增加证明了自噬刺激,巴佛洛霉素A1可区分对自噬通量的影响与自噬清除的阻断。LKE处理导致多种自噬途径蛋白的蛋白质水平或磷酸化状态发生变化,包括mTOR、p70S6激酶、unc-51样激酶-1(ULK1)、贝林1和LC3,其方式与雷帕霉素处理后观察到的效应基本相同。LKE的作用位点靠近mTOR,因为LKE和mTOR抑制剂雷帕霉素均未影响mTOR上游的结节性硬化复合物(TSC)磷酸化状态。共聚焦免疫荧光成像显示,LKE特异性降低了RG2细胞中mTOR(而非TSC2)与LAMP2(+)溶酶体的共定位,这是mTORC1介导的自噬抑制的必要事件,而雷帕霉素没有影响。通过短发夹RNA抑制LK结合衔接蛋白CRMP2(塌陷反应介导蛋白-2)导致自噬通量减少,表明LKE对mTOR定位的作用可能通过一种涉及CRMP2介导的细胞内运输的新机制发生。这些发现阐明了LKE在中枢神经系统疾病临床前模型中的作用机制,同时提示天然兰硫氨酸代谢物在调节中枢神经系统自噬中的可能作用。